1. Home
  2. BLNK vs SGHT Comparison

BLNK vs SGHT Comparison

Compare BLNK & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blink Charging Co.

BLNK

Blink Charging Co.

HOLD

Current Price

$0.75

Market Cap

89.3M

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$7.44

Market Cap

395.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLNK
SGHT
Founded
2009
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.3M
395.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BLNK
SGHT
Price
$0.75
$7.44
Analyst Decision
Buy
Buy
Analyst Count
7
8
Target Price
$2.13
$8.23
AVG Volume (30 Days)
8.2M
312.9K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$106,631,000.00
$76,052,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$17.87
$12.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$2.03
52 Week High
$2.65
$9.24

Technical Indicators

Market Signals
Indicator
BLNK
SGHT
Relative Strength Index (RSI) 39.11 42.80
Support Level $0.63 $7.28
Resistance Level $0.85 $8.19
Average True Range (ATR) 0.06 0.58
MACD 0.03 -0.21
Stochastic Oscillator 63.68 10.07

Price Performance

Historical Comparison
BLNK
SGHT

About BLNK Blink Charging Co.

Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Share on Social Networks: